These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9683826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
    Tsavaris N, Kosmas C, Mylonakis N, Bacoyiannis C, Kalergis G, Vadiaka M, Boulamatsis D, Iakovidis V, Kosmidis P.
    Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T, Secen N, Povazan Dj, Sabo A, Popovic J, Bursac D, Kakas M, Zaric B, Milovancev A.
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [Abstract] [Full Text] [Related]

  • 5. Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting.
    Póka R, Hernádi Z, Juhász B, Lampé L.
    Int J Gynaecol Obstet; 1993 Jul; 42(1):19-24. PubMed ID: 8103470
    [Abstract] [Full Text] [Related]

  • 6. Combination antiemetics for cisplatin chemotherapy.
    Sridhar KS, Donnelly E.
    Cancer; 1988 Apr 15; 61(8):1508-17. PubMed ID: 3280112
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K, Saito Y, Tominaga K.
    Am J Clin Oncol; 1993 Aug 15; 16(4):338-41. PubMed ID: 8392288
    [Abstract] [Full Text] [Related]

  • 9. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 10. Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
    Cognetti F, Pinnarò P, Carlini P, Conti EM, Cortese M, Pollera CF.
    Eur J Cancer Clin Oncol; 1984 Feb 15; 20(2):183-7. PubMed ID: 6368241
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec 15; 11(12):2396-404. PubMed ID: 8246029
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Roila F, Basurto C, Bracarda S, Picciafuoco M, Ballatori E, Del Favero A, Tonato M.
    Oncology; 1990 Dec 15; 47(5):415-7. PubMed ID: 2216296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A, Tripathi KD, Sharma M.
    Indian J Med Res; 2003 Jul 15; 118():33-41. PubMed ID: 14748464
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone.
    Frustaci S, Grattoni E, Tumolo S, Crivellari D, Figoli F, Galligioni E, Veronesi A, Tirelli U, Grigoletto E.
    Cancer Chemother Pharmacol; 1986 Jul 15; 17(1):75-9. PubMed ID: 3698180
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients.
    Sorbe B, Hallén C.
    Eur J Gynaecol Oncol; 1991 Jul 15; 12(1):31-7. PubMed ID: 2050157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.